Trivitron Healthcare Pvt. Ltd.

Labsystems Diagnostics test is designed for the quantitative in vitro determination of galactose1phosphate uridyltransferase (GALT) activity in blood samples dried on filter paper. This kit is intended for screening newborns for classic galactosemia which is caused by the inability to convert Galactose1phosphate into glucose1phosphate due to GALT deficiency.

Hereditary galactosemia is among the most common carbohydrate metabolism disorders and can be life threatening illness during the newborn period. Galactosemia is an inherited defect of galactose metabolism caused by an enzyme deficiency. It is an autosomal recessive defect and occurs at the average worldwide incidence of aprox. 1 50000 but varies geographically. Cardinal features are hepatomegaly cataracts and mental retardation. Surviving babies who remain untreated may have mental retardation and other damage to the brain and nervous system. Classic galactosemia cannot be cured but it can be effectively treated by eliminating lactose and galactose from the diet like milk and all dairy products if detected in early stage of life and disease course.

Features:

• Quantitative fluorometric determination
• Automated plate to plate transfer procedure to avoid any disc floating interference.
• No false positives caused by G6PD deficiency
• Single kit for both manual and automated procedures

Biocard Rapid Midstream Rapid test for hCG in Urine developed based on Antigen sandwich by Lateralflow immunochromatography assay for the qualitative detection of hCG in urine for determination of pregnancy. All the accessories needed for the sampling and testing are included.

Biocard Rapid Midstream Rapid test for hCG in Urine developed based on Antigen sandwich by Lateralflow immunochromatography assay for the qualitative detection of hCG in urine for determination of pregnancy.

• All the accessories needed for the sampling and testing are included.
• Works on Midstream Urine

 

Features:

• Ability to detect hCG with a great sensitivity and specificity by Antigen sandwich.
• Convenient pack sizes
• Simple to perform
• Needs no equipment
• Excellent sensitivity and specificity.
• ISO -13485 2012 and GMP compliant manufacturing process.

 

Note: Biocard Midstream Rapid test for the determination of Human Choronic Gonadotropin (hCG) in urine

Kiran Sonorad V40 offers a Comprehensive Diagnostic experience with Superior Image quality, multiple measurement packages. It supports wide variety of probes to suit major applications like Obstretics/Gynaecology, Radiology with high performance SonoRad V40 supports cardiology features like TDI as well and CW/PW/HPRF is available with supporting probe.  SonoRad V40 will be a right choice for multi-dimensional and whole body Color Doppler with high performance to cost ratio.

Kiran Sonorad V20 offers a Comprehensive Diagnostic experience with Superior Image quality, multiple measurement packages. It supports wide variety of probes to suit major applications like Obstretics/Gynaecology, Radiology with high performance SonoRad V20 supports cardiology features like TDI as well and CW/PW/HPRF is available with supporting probe.  SonoRad V20 will be a right choice for multi-dimensional and whole body Color Doppler with high performance to cost ratio.

Breast Imaging for Today and Beyond.The Selenia Dimensions 2D system is the ideal choice for centers that want a flexible digital breast imaging platform with state-of-the-art image acquisition and display features.Digital Mammography and Breast Tomosynthesis from Hologic.Selenia Dimensions starts with technology similar to that of our celebrated Selenia full-field digital mammography system. With its large amorphous selenium detector, it too can “direct capture” conventional digital mammograms with the same extraordinary clarity you’ve come to expect from Selenia. And incorporating a tungsten tube means we can do it with even less patient radiation dose than before. But Selenia Dimensions takes you to the next step in detection: fast, low-dose, high-quality tomosynthesis images of the breast.

A flexible digital breast imaging platform providing state-of-the-art image acquisition and display:

The Selenia^® Dimensions™ 2D full-field digital mammography system, the newest addition to our family of breast imaging solutions, offers the superior image quality you have come to expect from Hologic and can be configured for 3D breast imaging when and if breast tomosynthesis is approved by the FDA.

The Selenia Dimensions 2D acquisition workstation features integrated x-ray control capabilities and an image acquisition console that offers a unique ergonomic design and an efficient user interface. An intuitive touchscreen display and an icon-driven user interface make it easy to use, improving patient throughput.

Images can be acquired and reviewed within seconds, and the imaging parameters can be adjusted quickly to meet the requirements of the examination. Several weeks of mammography examinations can stay locally on the acquisition workstation, to efficiently accommodate recalls.

Selenia Dimensions 2D has built-in quality controls which streamline system QC and assures optimal performance. Reject and repeat analysis reports are generated automatically, greatly simplifying administrative reporting. Altogether it’s a better way to capture, analyze and share information across the team.

A Way to Be Surer. SoonerL: Breast tomosynthesis is the newly emerging method for delivering high quality images of breast tissue in three dimensions. We have good reason to believe it will be a quantum leap forward in breast cancer detection. Selenia Dimensions rapidly captures a series of low-dose images at different views around the breast.

From these original images, we can quickly compute a “synthetic tomogram” sequence, separating the full depth of tissue into discrete one-millimeter layers. This separation of tissue into virtual layers helps the physician clearly see features which might be obscured in a traditional mammogram.

Specification:

2D Imaging:

• Delivers superb image quality at reduced dose 
• Offers efficient workflow and a number of advanced features 

Tomo Imaging:

• Can be used as an advanced diagnostic tool 
• Offers superb diagnostic clarity at reduced dose 

Combo Imaging:

• Designed to offer higher diagnostic accuracy in screening mammography 
• Dose efficient option to maintain best image quality and workflow efficiency

A versatile tool for Newborn Screening with high format flexibility and detection sensibility.

Labsystems Diagnostics NS200 is a user-friendly and affordable fluorescence reader, designed to cater to the Newborn Screening needs of today's applications. For uncompromised performance in all detection modes, the NS200 uses advanced optics and high-performance detectors. The NS200 offers versatile measuring modes and formats with exceptional sensitivity levels.

Features:

• Users can select the desired features to create the perfect reader for their needs, with the option to upgrade as requirements change. The NS200 offers excellent sensitivity, multiplexing capabilities and high formate flexibility, including 6- to 384-well microplates (designed for Cell-based assays and/or high throughput library screening) and PCR plates.
• The NS200 can be used for all Labsystems Diagnostics NBS applications and many other laboratory developed tests or commercial assays. NS200 can also be integrated onto NS2400 fully automatic newborn screening platform and thus makes the transition from semi-automated assay processing to fully integrated-high throughput sample analysis smoother and with lower validation requirements.

 

Technical Specifications:

The NS200 offers a wide range of detection modes:

• Fluorescence intensity (top reading)
• Fluorescence resonance energy transfer (FRET)
• Time resolved fluorescence energy transfer (TR-FRET) like HTRF
• Time resolved fluorescence (TRF)
•  Absorbance
• Incubation and shaking
• Temperature control
• Sample measurement with various plate formats

 

Software: A versatile user interface and powerful data reduction capabilities enable the optimization of sophisticated experimental work as well as making routine tasks easy. As an upgrade, there is also available a highly functional analysis software, which is in compliance with FDA21 CFR part 11 and European Directive 98/79/EC (IVD-D).

 

Benefits:

• Advanced Optics
• High-performance Detectors
• Fully upgradeable
• Data Exportable to Excel
• Easy to use
• Reliable
• Great After-sale Support

Immediate on-site Covid 19 Antigen Testing. BIOCARD Pro COVID-19 Rapid Antigen kit is a chromatographic immunoassay for the qualitative detection of specific antigens to COVID-19 present in human nasopharyngeal swab

Biocard Rapid test for HBsAg rapid test is an Antigen sandwich immunochromatographic lateral flow test for the qualitative detection of Hepatitis B Virus surface antigens.All the accessories needed for the sampling and testing are included.Works on Serum/Plasma.

Biocard Rapid test for HBsAg rapid test is an Antigen sandwich immunochromatographic lateral flow test for the qualitative detection of Hepatitis B Virus surface antigens:

• All the accessories needed for the sampling and testing are included.
• Works on Serum/Plasma.

 

Features:

• Ability to detect All known 11 subtypes of HBsAg by Antigen sandwich.
• Convenient pack sizes.
• Simple to perform.
• Needs no equipment.
• Excellent sensitivity and specificity.
• ISO -13485 2012 and GMP compliant manufacturing process

 

Note: Biocard Rapid Test for Hepatitis B Surface Antigen (HBsAg) in Human Serum/Plasma. 

This kit is intended for qualitative detection in vitro of Orf1ab and N genes of Novel Coronavirus 2019-nCoV which are found in throat swab, sputum and alveolar lavage fluid samples of suspected cases of pneumonia, suspected cases of clustering, and other patients who need to carry out diagnosis or differential diagnosis of Novel Coronavirus 2019-nCoV infection.

The detection is done in one step real time PCR format where the reverse transcription and the subsequent amplification of specific target sequence occur in the same reaction well. The isolation RNA target is transcribed generating complementary DNA by reverse transcriptase which is followed by the amplification of a conserved region of ORF1 ab, N and RNaseP gene (Internal Standard) for SARS CoV-2 detection using specific primer & fluorescent labelled probe.